Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07800897
PHASE1

A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the food effect and drug interactions on drug levels of Navlimetostat in health adult female participants

Official title: A Phase 1, Open-label, Randomized, Pharmacokinetic Study to Assess the Drug Interactions and Food Effect of Navlimetostat (BMS-986504) in Healthy Female Participants

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-08-26

Completion Date

2027-03-25

Last Updated

2026-09-02

Healthy Volunteers

Yes

Interventions

DRUG

Navlimetostat

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Rifampin

Specified dose on specified days

DRUG

Midazolam

Specified dose on specified days

DRUG

Pantoprazole

Specified dose on specified days